Questions and Answers About AstraZeneca Vaccine Stopping
Spain has followed in the wake of other European countries and has decided to stop the distribution of the Oxford / AstraZeneca vaccine for at least 15 days. This turn comes after the health authorities, including the Ministry of Health, the EMA and the WHO, insistently recommended its use until last Friday. Some countries had even started lift the restriction that people over 55 years of age should not be inoculated. The reason for this change: a series of cases of rare cerebral thrombosis presented in people who received the vaccine but that, at the moment, there is no evidence that they are linked to it. Next, we solve some doubts about what until now was one of the main sera in the European and Spanish immunization strategy.
Why has Spain stopped vaccination with AstraZeneca when last Friday it said there were no reasons?
This Monday, the Ministry of Health announced that Oxford / AstraZeneca vaccination “provisionally and temporarily” suspended for 15 days. Meanwhile, the European Medicines Agency (EMA) will carry out a report on the cases of thrombosis present in about thirty people – four of them in Spain – who had received the serum since its authorization on January 29.
Only three days ago, Health did not see reasons to stop its distribution and the EMA defended that the blood thromboses detected in countries such as Denmark or Austria were not related to the vaccine. The WHO – World Health Organization – also issued a message of reassurance about how important it was to “continue using” AstraZeneca serum to achieve the immunization goals set. This Monday, however, several European countries have joined the previous cascade of suspensions; Among them, Spain, which announced it at the last minute despite the fact that some regions had taken the decision unilaterally last week.
Mónica Zas and Elena Cabrera write.